Related references
Note: Only part of the references are listed.The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2
Lazaro Gil et al.
IMMUNOLOGY AND CELL BIOLOGY (2015)
A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice
Alienys Izquierdo et al.
ARCHIVES OF VIROLOGY (2014)
Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virus
Edith Suzarte et al.
ARCHIVES OF VIROLOGY (2014)
Type I Interferon Signals in Macrophages and Dendritic Cells Control Dengue Virus Infection: Implications for a New Mouse Model To Test Dengue Vaccines
Roland Zuest et al.
JOURNAL OF VIROLOGY (2014)
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
Maria Rosario Capeding et al.
LANCET (2014)
Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus
Laura Lazo et al.
MICROBIOLOGY AND IMMUNOLOGY (2014)
Capsid protein: Evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeys
Lazaro Gil et al.
VIROLOGY (2014)
Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus
Ernesto Marcos et al.
ARCHIVES OF VIROLOGY (2013)
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells
Daniela Weiskopf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice
Lazaro Gil et al.
JOURNAL OF GENERAL VIROLOGY (2012)
Protection from Secondary Dengue Virus Infection in a Mouse Model Reveals the Role of Serotype Cross-Reactive B and T Cells
Simona Zompi et al.
JOURNAL OF IMMUNOLOGY (2012)
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
Arunee Sabchareon et al.
LANCET (2012)
The Chimeric Protein Domain III-Capsid of Dengue Virus Serotype 2 (DEN-2) Successfully Boosts Neutralizing Antibodies Generated in Monkeys upon Infection with DEN-2
Iris Valdes et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Interference and Facilitation Between Dengue Serotypes in a Tetravalent Live Dengue Virus Vaccine Candidate
Kathryn B. Anderson et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
The two component adjuvant IC31® potentiates the protective immunity induced by a dengue 2 recombinant fusion protein in mice
Lidice Bernardo et al.
VACCINE (2011)
A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness
V. J. Gunther et al.
VACCINE (2011)
Nucleocapsid-like particles of dengue-2 virus enhance the immune response against a recombinant protein of dengue-4 virus
Laura Lazo et al.
ARCHIVES OF VIROLOGY (2010)
Heterologous prime-boost strategy in non-human primates combining the infective dengue virus and a recombinant protein in a formulation suitable for human use
Iris Valdes et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
CD4+ T Cells Are Not Required for the Induction of Dengue Virus-Specific CD8+ T Cell or Antibody Responses but Contribute to Protection after Vaccination
Lauren E. Yauch et al.
JOURNAL OF IMMUNOLOGY (2010)
A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes in Flavivirus-Naive Adults
Dennis Morrison et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Development of a recombinant tetravalent dengue virus vaccine: Innmunogenicity and efficacy studies in mice and monkeys
David E. Clements et al.
VACCINE (2010)
Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CD4+ and CD8+ cells against viral encephalitis in mice
Lazaro Gil et al.
INTERNATIONAL IMMUNOLOGY (2009)
A Protective Role for Dengue Virus-Specific CD8+ T Cells
Lauren E. Yauch et al.
JOURNAL OF IMMUNOLOGY (2009)
The Cellular Immune Response Plays an Important Role in Protecting Against Dengue Virus in the Mouse Encephalitis Model
Lazaro Gil et al.
VIRAL IMMUNOLOGY (2009)
A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice
Iris Valdes et al.
VIROLOGY (2009)
Mouse models of dengue virus infection and disease
Lauren E. Yauch et al.
ANTIVIRAL RESEARCH (2008)
CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy
Hso-Chi Chaung
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
Evidence that a mechanism for efficient flavivirus budding upregulates MHC class I
M Lobigs et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children
A Sabchareon et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells
JJ Hung et al.
JOURNAL OF VIROLOGY (2004)
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells
WD Crill et al.
JOURNAL OF VIROLOGY (2001)
Chimeric yellow fever/dengue virus as a candidate dengue vaccine: Quantitation of the dengue virus-specific CD8 T-cell response
RG Van Der Most et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
